Why Breast Cancer Therapy Tamoxifen May Lead to Higher Risk of Uterine Cancer
August 22, 2025
August 22, 2025
BOSTON, Massachusetts, Aug. 22 [Category: BizHospital] -- Mass General Brigham issued the following news release:
* * *
Why Breast Cancer Therapy Tamoxifen May Lead to Higher Risk of Uterine Cancer
*
Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- to 7-fold increased risk of developing uterine cancer within 2-5 years of tamoxifen treatment compared to the general popul . . .
* * *
Why Breast Cancer Therapy Tamoxifen May Lead to Higher Risk of Uterine Cancer
*
Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- to 7-fold increased risk of developing uterine cancer within 2-5 years of tamoxifen treatment compared to the general popul . . .